Literature DB >> 9391181

Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography.

D C Crawford1, M A Flower, B E Pratt, C Hill, J Zweit, V R McCready, C L Harmer.   

Abstract

The aim of this paper was to compare ultrasound (US) assessment of thyroid volume with that obtained by positron emission tomography (PET), in patients scheduled for adaptive radioiodine therapy, in which 50 Gy was prescribed to the functional PET volume. Firstly a pilot study was performed to ascertain the optimum method for US assessment of thyroid volume. Then 17 comparative measurements of thyroid volume by US and PET were made on 15 patients (two male and thirteen female, ages 28-73 years) with suspected Graves' disease. This comparison showed that in normal sized and enlarged thyroid glands (n=13), the ratio of functional PET to anatomical US volume was approximately 2:3. However, using the same ellipsoid model, PET and US assessment of anatomical volume agreed within the measurement errors. Owing to the presence of nodules and non-uniform distribution of radioiodine, the functional PET volume and anatomical US volume are often not equivalent. If high-resolution emission tomography (e.g. PET) is unavailable, the comparative data presented in this paper could be used to derive the functional volume from the US volume for calculating functional thyroid dose in hyperthyroid patients undergoing radioiodine therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391181     DOI: 10.1007/s002590050176

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Higher frequency of thyroid tumors in the right lobe.

Authors:  Alois Gessl; Wolfgang Raber; Anton Staudenherz; Alexander Becherer; Oskar Koperek; Andrea Hofmann
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  Use of spiral computed tomography volumetry for determining the operative approach in patients with Graves' disease.

Authors:  June Young Choi; Kyu Eun Lee; Do Hoon Koo; Kyu Hyung Kim; Eun young Kim; Dong Sik Bae; Sung Eun Jung; Yeo-Kyu Youn
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

3.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 4.  Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.

Authors:  Lutz S Freudenberg; Walter Jentzen; Alexander Stahl; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

5.  Guidelines for radioiodine therapy of differentiated thyroid cancer.

Authors:  M Luster; S E Clarke; M Dietlein; M Lassmann; P Lind; W J G Oyen; J Tennvall; E Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

6.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

Authors:  L S Freudenberg; G Antoch; W Jentzen; R Pink; J Knust; R Görges; S P Müller; A Bockisch; J F Debatin; W Brandau
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

7.  Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.

Authors:  L S Freudenberg; G Antoch; R Görges; J Knust; R Pink; W Jentzen; J F Debatin; W Brandau; A Bockisch; J Stattaus
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

8.  Comparative thyroid gland volume by two methods: Ultrasonography and planar scintigraphy.

Authors:  Jarosław Pleśniak; Stanisław Urbański
Journal:  Pol J Radiol       Date:  2012-04

9.  A partial volume effect correction tailored for 18F-FDG-PET oncological studies.

Authors:  F Gallivanone; C Canevari; L Gianolli; C Salvatore; P A Della Rosa; M C Gilardi; I Castiglioni
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

10.  The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.

Authors:  Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; W J Sluiter; Bruce H R Wolffenbuttel; Rudi A J O Dierckx; Thera P Links
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.